RankAlpha logo
Back to Rankings

EOLS

EvolusA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
EOLS vs peer average
72/100
EOLS vs. peer average (A vs. B)
Grade spread
A 3 · B 2 · C 1 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MYGN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $407.07M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMYGNMyriad Genetics
EOLS
Evolus
MYGN
Myriad Genetics
Grade
A
F
Momentum
91
6
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MYGN

EOLS / MYGN
Grade Position
Above peers
EOLS vs. peer average (A vs. B)
72/100
Momentum
91
EOLS
Value
41
EOLS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EOLS
1
MYGN
Myriad Genetics Inc Common
F
20/100
+4
2
STRO
Sutro Biopharma Inc Common
A
100/100
Even
3
ADCT
ADC Therapeutics Ltd Common
C
60/100
+2
4
MNPR
Monopar Therapeutics Inc Common
A
100/100
Even
5
CATX
Perspective Therapeutics Inc Common
D
40/100
+3
MYGN is the first peer returned for this comparison set.